Strategies for regulation of innovative non-vaccine biologics for disease prevention in China: a SWOT analysis
With globally increasing diversification of biomedical technologies, a large number of innovative biologics, such as long-acting monoclonal antibodies, have shown good preventive effects in clinical trials. However, in accordance with current legal framework in China, such biologics cannot be regist...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Kitap |
| Baskı/Yayın Bilgisi: |
Editorial Office of Chinese Journal of Public Health,
2024-01-01T00:00:00Z.
|
| Konular: | |
| Online Erişim: | Connect to this object online. |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
| Yer Numarası: |
A1234.567 |
|---|---|
| Kopya Bilgisi 1 | Kütüphanede |